You are viewing an incomplete version of our website. Please click to reload the website as full version.
Areas: ,

Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-big gamma phosphorylation

Dok1 promotes adipocyte hypertrophy, state scientists of the Kobe University in Japan. The protein antagonises the inhibitory effect of on ()- and may predispose the individual to diet-induced obesity.

The study showed that Dok1 regulates adiposity. Mice on a high-fat diet expressed Dok1 stronger in their white adipose tissue. Adipocytes without this adapter were smaller and did not respond as strongly to the dietary manipulation. Dok1-deficient mice were leaner and exhibited enhanced glucose tolerance and sensitivity in comparison to wild-type mice. In a different experiment the scientists looked at embryonic from Dok1-deficient mice. They were impaired in their adipogenic differentiation. This defect was accompanied by an increased activity of the protein kinase and a consecutive increase in the phosphorylation of on Ser112. When this site is mutated, the development of the lean phenotype is blocked because Dok1 remains absent. receptor substrate (IRS)-1 and IRS-2 have dominant roles in the action of 1, but other substrates of the receptor kinase, such as , , SH2-B and , are also physiologically relevant. The protein downstream of tyrosine kinases-1 (Dok1) is known to function as a multi-site adapter molecule in signalling.

Related antibodies on antibodies-online.com:

Dok1

Adipocytes

SH2-B

Antibodies for the research area metabolism:

Antibodies for the research area signalling: